durvalumab - Robuta Search

https://adisinsight.springer.com/trials/700285689?error=cookies_not_supported&code=b1618a42-3ccd-4a23-9f7a-0093d2ba11e0 Single arm, open label, signal seeking, phase IIa trial of the activity of Durvalumab (MEDI4736) in... This is a substudy of the Cancer Molecular Screening and Therapeutics (MoST) Program, which is registered on ANZCTR with ID ACTRN12616000908437. This substudy https://adisinsight.springer.com/drugsafety/803574261?error=cookies_not_supported&code=0b61bedf-a855-44bb-8d78-163e4735fac8 Durvalumab - AdisInsight A 71-year-old woman developed diabetes mellitus and diabetic ketoacidosis following treatment with durvalumab for non-small cell adenocarcinoma.The woman had a durvalumab adisinsight https://www.techtransfer.nih.gov/patent/e-136-2018-1-tr-26 Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab | Technology Transfer https://adisinsight.springer.com/drugsafety/803925804?error=cookies_not_supported&code=ed46ec81-b1fa-4437-a023-db42d221b9a1 Durvalumab - AdisInsight Six patients with stage III non-small cell lung cancer developed grade 3 or higher pneumonitis following treatment with radiochemotherapy and subsequent durvalumab adisinsight https://pubmed.ncbi.nlm.nih.gov/37459133/ A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally... In patients with locally advanced unresectable HCC, the combination of Y90-radioembolization and durvalumab demonstrated promising efficacy and safety,... https://adisinsight.springer.com/trials/700313721?error=cookies_not_supported&code=739c7439-9cc4-4230-b091-97ff200f6785 A retrospective study assessing durvalumab in stage III unresectable non-small cell lung cancer... This study evaluated durvalumab in stage III unresectable non-small cell lung cancer (NSCLC) patients https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-durvalumab-and-domvanalimab-for-non-small-cell-lung-cancer-pacific-8 Cancer Research UK | A trial of durvalumab and domvanalimab for non small cell lung cancer... This trial is looking at durvalumab and domvanalimab for non small cell lung cancer that has grown into surrounding tissues. cancer research uk https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-durvalumab-for-non-small-cell-lung-cancer-pacific-4 A trial looking at durvalumab for non small cell lung cancer (PACIFIC-4) This trial is for people with non small cell lung cancer who are going to have a type of radiotherapy called stereotactic ablative radiotherapy (SABR). small cell lung cancer https://publikationen.uni-tuebingen.de/xmlui/handle/10900/103649?show=full A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT03732677&r=1 Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in... Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC durvalumab gemcitabine cisplatin treatment adjuvant https://adisinsight.springer.com/trials/700296324?error=cookies_not_supported&code=9c601fc7-be5a-41d0-b53e-4746914e91c5 A Pilot Study of Olaparib and Durvalumab in Patients With Metastatic Triple Negative Breast Cancer... This pilot study is evaluating the efficacy of combination of PARP inhibitor (olaparib) and immune therapy (durvalumab) in patients with Triple Negative Breast https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-chemoradiotherapy-and-durvalumab-for-invasive-bladder-cancer-radio A trial of chemoradiotherapy and durvalumab for invasive bladder cancer (Radio) This trial is looking at adding durvalumab to chemoradiotherapy for people with bladder cancer that has grown into the muscle wall. bladder cancer trial chemoradiotherapy https://www.cancerresearchuk.org/about-cancer/treatment/drugs/durvalumab-tremelimumab Durvalumab and tremelimumab | Cancer drugs | Cancer Research UK Durvalumab and tremelimumab is a treatment for hepatocellular carcinoma (HCC). Find out about how you have it, possible side effects and other important... cancer drugs durvalumab tremelimumab research uk https://adisinsight.springer.com/drugsafety/803924412?error=cookies_not_supported&code=0f9c80bd-4d46-4aae-9100-7cf096734b3c Durvalumab - AdisInsight A 61-year-old man with recurrent perihilar cholangiocarcinoma experienced grade 1 skin toxicity during treatment with durvalumab for intrahepatic metastases. durvalumab adisinsight https://ec2-3-220-198-172.compute-1.amazonaws.com/n-engl-j-med-2025393217-230-gastric-cancer/ Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer - FCS Hematology Oncology... Aug 19, 2025 - The MATTERHORN trial assessed patients with resectable gastric cancer/gastroesophageal junction cancer and assigned them 1:1 to perioperative durvalumab 1500... perioperative durvalumab gastric https://pubmed.ncbi.nlm.nih.gov/41033130/ Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung... https://adisinsight.springer.com/trials/700302008?error=cookies_not_supported&code=d75a89c3-0756-459e-b9ab-db86032f8ecd A Phase II Study of Durvalumab (MEDI4736) Plus Tremelimumab for the Treatment of Patients with... The purpose of this exploratory phase II, stratified, multi-centre, open label, prospective, combination therapy is to evaluate the efficacy and safety of https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-durvalumab-with-chemotherapy-for-biliary-cancer-topaz-1 A trial of durvalumab with chemotherapy for biliary cancer (TOPAZ-1) This trial is looking at durvalumab with chemotherapy for biliary cancer that cannot be removed by surgery or has spread to another part of the body. trial durvalumab https://pubmed.ncbi.nlm.nih.gov/40590327/ Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as... Efficacy and safety in the Japan subset were generally consistent with outcomes in the DUO-E ITT population. This Japanese subset analysis of DUO-E supports... followed by durvalumab plus carboplatin paclitaxel https://pubmed.ncbi.nlm.nih.gov/40433908/ A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination... In real-world clinical practice, Dur + Tre is highly effective as a first-line treatment for u-HCC. Additionally, patients with SD who met the SD-R criteria... a novel approach https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-03900&r=1 A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of... A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-datopotamab-deruxtecan-durvalumab-advanced-triple-negative-breast-cancer-diamond A trial looking at datopotamab deruxtecan and durvalumab for advanced triple negative breast cancer... This trial is comparing datopotamab deruxtecan with durvalumab and datopotamab deruxtecan for triple negative breast cancer. https://adisinsight.springer.com/drugsafety/803906189?error=cookies_not_supported&code=7cf8ea13-91da-4bad-b3bb-60c8657bc9f0 Durvalumab/tremelimumab - AdisInsight A 59-year-old man developed myocarditis, myositis and myasthenia gravis (MG) during treatment with tremelimumab and durvalumab for hepatocellular carcinoma durvalumab tremelimumab adisinsight https://adisinsight.springer.com/drugsafety/803928994?error=cookies_not_supported&code=6f35cee8-669a-49fc-8768-562d3338c451 Durvalumab/Tremelimumab - AdisInsight Fifteen patients [age and sex not stated] with macrovascular invasion-positive advanced hepatocellular carcinoma in a phase Ib study received systemic durvalumab tremelimumab adisinsight https://www.nice.org.uk/guidance/ta1099 Overview | Durvalumab for treating limited-stage small-cell lung cancer after platinum-based... Evidence-based recommendations on durvalumab (Imfinzi) for treating limited-stage small-cell lung cancer that has not progressed after platinum-based... small cell lung cancer https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT02431559&r=1 Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian... Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer https://boris-portal.unibe.ch/entities/publication/71bc8823-ba4f-49bb-890c-f1f2ec3f40d3 SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2)... PURPOSE For patients with resectable stage IIIA(N2) non-small-cell lung cancer, neoadjuvant chemotherapy with cisplatin and docetaxel followed by surgery... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-durvalumab-after-treatment-for-bladder-cancer-bl13 A trial of durvalumab after treatment for bladder cancer (BL13) This trial is looking at durvalumab after surgery, chemotherapy and radiotherapy for bladder cancer that has grown into the muscle wall. after treatment bladder cancer trial durvalumab https://profiles.wustl.edu/en/publications/durvalumab-in-combination-with-chemoradiotherapy-for-patients-wit/ Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III... for patients durvalumab combination chemoradiotherapy stage https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1103927/full Frontiers | Efficacy and safety of consolidation durvalumab after chemoradiation therapy for stage... Background: The current review aimed to pool real-world evidence on the efficacy and toxicity of consolidation durvalumab for stage III unresectable non-smal... efficacy and safety https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-datopotamab-deruxtecan-and-durvalumab-for-breast-cancer-tropion-breast04 A trial looking at datopotamab deruxtecan and durvalumab for breast cancer (TROPION-Breast04) This trial is comparing datopotamab deruxtecan and durvalumab with pembrolizumab and standard chemotherapy before surgery for breast cancer. https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-nab-paclitaxel-with-cc-486-and-durvalumab-for-advanced-non-small-cell-lung-cancer A trial of nab-paclitaxel with CC-486 and durvalumab for advanced non small cell lung cancer This trial is for people who have already had treatment for their advanced non small cell lung cancer. https://www.techtransfer.nih.gov/patent/e-136-2018-1-de-16 Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab | Technology Transfer https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-azd5069-and-durvalumab-for-cancer-that-started-in-the-liver-cubic Cancer Research UK | A trial of AZD5069 and durvalumab for cancer that started in the liver (CUBIC) This trial is looking at AZD5069 and durvalumab for the most common type of liver cancer called hepatocellular carcinoma (HCC). https://adisinsight.springer.com/trials/700319637?error=cookies_not_supported&code=912c5a6a-da68-406b-8006-b325cb6dd596 A multi-stage randomised trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil... It is hypothesised that the known synergistic effects of chemotherapy and radiotherapy are augmented by the addition of further therapies and specifically that multi stage https://www.techtransfer.nih.gov/patent/e-136-2018-1-hu-19 Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab | Technology Transfer https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00772 Durvalumab and Tremelimumab, Oleclumab, or Monalizumab in Treating Patients with Colorectal Cancer... Durvalumab and Tremelimumab, Oleclumab, or Monalizumab in Treating Patients with Colorectal Cancer with Lung or Liver Metastases That Can Be Removed by Surgery https://pmc.ncbi.nlm.nih.gov/articles/PMC10427431/ First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal... Although patients with microsatellite instable metastatic colorectal cancer (CRC) benefit from immune checkpoint blockade, chemotherapy with targeted therapies... first line